510(k) K895997
K895997 is an FDA 510(k) premarket notification submitted by Lipogen, Inc. for the device "RHEUMELISA ASSAY FOR RNP AUTOANTIBODIES". The FDA issued a decision of Substantially Equivalent on Nov 6, 1989. The device falls under product code LKO (Anti-Rnp Antibody, Antigen And Control), a Class II device regulated under 21 CFR 866.5100. Lipogen, Inc. has 14 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 6, 1989
- Date Received
- Oct 13, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Anti-Rnp Antibody, Antigen And Control
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Lipogen, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.